GSK Investigational Site

Preston, Lancashire PR2 9HT

0 studies enrolling now · 3 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Anaemia, Aspergillosis, Allergic Bronchopulmonary

Studies at this site

• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — Completed
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — Completed
• Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis — Completed